High levels of CD177+ neutrophils are activated and significantly enriched at the tumor sites where these neutrophils are interacting with tissue, activating particular signaling molecules, leading to the negative regulation of the PI3K/AKT and MAPK/ERK pathways, which may inhibit tumor proliferation, metastasis, and invasion. The gene discussed is CD177; the disease is neoplasm.